Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Oligodendroglioma.

Thomas L Ellis¹, Volker W Stieber, Rebekah C Austin

¹Department of Neurosurgery, Wake Forest University School of Medicine, Winston-Salem, NC 27105, USA. tlellis@wfubmc.edu

Current Treatment Options in Oncology

|October 31, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825.

Neuro-oncology·2024

Same author

NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma.

Neuro-oncology advances·2023

Same author

Germline polymorphisms in <i>MGMT</i> associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.

Neuro-oncology advances·2022

Same author

Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study.

Journal of medical economics·2019

Same author

Cavernous sinus metastases treated with gamma knife<sup>TM</sup> stereotactic radiosurgery.

Journal of radiosurgery and SBRT·2018

Same author

The Protective Action Encoding of Serotonin Transients in the Human Brain.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2018

Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026

Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026

Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026

Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026

Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026

Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026

See all related articles

Advances in adjuvant therapies, molecular understanding, and surgical techniques have improved survival for oligodendroglial tumors. Early diagnosis and tailored treatment, including surgery, radiation, and chemotherapy, offer better patient outcomes and potential cures.

Area of Science:

Neuro-oncology
Molecular Biology
Neurosurgery

Background:

Oligodendroglial tumors historically presented a poor prognosis despite aggressive treatment.
Recent advancements have significantly improved patient survival and cure rates.

Purpose of the Study:

To review current therapeutic strategies for oligodendroglial tumors.
To highlight the impact of recent advancements on patient outcomes.

Main Methods:

Review of recent literature on oligodendroglial tumor treatment.
Analysis of improvements in molecular biology, surgical techniques, and chemotherapy.
Discussion of diagnostic and treatment protocols based on tumor grade.

Main Results:

Related Experiment Videos

Effective adjuvant therapies have been developed, prolonging survival and offering cures.
Improved understanding of molecular biology, surgical techniques, and chemotherapy have reduced toxicity.
Tailored treatment approaches based on tumor grade (low vs. high) are crucial.

Conclusions:

Maximum surgical resection or biopsy is recommended at diagnosis.
Low-grade tumors may be monitored, with radiation upon progression.
High-grade tumors warrant upfront radiation and potentially chemotherapy; clinical trials are vital for future progress.